HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[A comparison of the sialyl SSEA-1 antigen and CEA in the histology of malignant mesothelioma, with special reference to adenocarcinoma of the lung].

Abstract
Tumor tissues obtained from 5 cases of malignant mesothelioma and from 5 cases of primary adenocarcinoma of the lung have been studied on staining with the sialyl SSEA-1 antibody by the PAP method. Results in all cases of a malignant mesothelioma (both Epithelioid and Sarcomatous pattern) were absolutely negative. All cases of lung cancer, however, were positive, though in differing degrees. In evaluating a malignant mesothelioma, many reports have indicated that the negativity of CEA staining is useful in achieving the differential diagnosis from lung cancer. The sensitivity of the staining by sialyl SSEA-1 was found to be far better than that of CEA in examining either malignant mesothelioma or lung cancer. Thus, we found that not only CEA but also sialyl SSEA-1 antigen staining was useful for the diagnosing of a malignant mesothelioma.
AuthorsT Kishimoto, K Okada, F Shimamoto, T Sato, T Ono
JournalGan no rinsho. Japan journal of cancer clinics (Gan No Rinsho) Vol. 34 Issue 14 Pg. 1951-5 (Nov 1988) ISSN: 0021-4949 [Print] Japan
PMID2462647 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Antigens, Neoplasm
  • Carcinoembryonic Antigen
  • Glycolipids
  • Lewis X Antigen
Topics
  • Adenocarcinoma (immunology, pathology)
  • Aged
  • Aged, 80 and over
  • Antigens, Neoplasm (analysis)
  • Carcinoembryonic Antigen (analysis)
  • Diagnosis, Differential
  • Female
  • Glycolipids (analysis)
  • Humans
  • Lewis X Antigen
  • Lung Neoplasms (immunology, pathology)
  • Male
  • Mesothelioma (immunology, pathology)
  • Staining and Labeling (methods)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: